JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2006; 48:708-714, doi:10.1016/j.jacc.2006.04.081 (Published online 21 July 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2006.04.081v1
48/4/708    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Strandberg, T. E.
Right arrow Articles by Miettinen, T. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strandberg, T. E.
Right arrow Articles by Miettinen, T. A.

CLINICAL RESEARCH: LIPIDS AND CARDIOVASCULAR DISEASE

Cholesterol and Glucose Metabolism and Recurrent Cardiovascular Events Among the Elderly

A Prospective Study

Timo E. Strandberg, MD, PhD*,{dagger},*, Reijo S. Tilvis, MD, PhD{ddagger}, Kaisu H. Pitkala, MD, PhD{ddagger} and Tatu A. Miettinen, MD, PhD{ddagger}

* Department of Public Health Science and General Practice, University of Oulu, Oulu, Finland
{dagger} Oulu University Hospital, Unit of General Practice, Oulu, Finland
{ddagger} Department of Medicine, Clinic of Internal Medicine and Geriatrics, University of Helsinki, Helsinki, Finland.

Manuscript received December 30, 2005; revised manuscript received April 13, 2006, accepted April 18, 2006.

* Reprint requests and correspondence: Dr. Timo E. Strandberg, Department of Public Health Science and General Practice, University of Oulu, PO Box 5000, FIN-90014, Oulu, Finland. (Email: timo.strandberg{at}oulu.fi).

OBJECTIVES: The aim of this research was to evaluate the prognostic value of cholesterol absorption assessed with the serum cholestanol-to-cholesterol concentration ratio (lower level reflects decreased cholesterol absorption) among elderly cardiovascular patients (DEBATE [Drugs and Evidence-Based Medicine in the Elderly] study).

BACKGROUND: The components of the metabolic syndrome have been unexpectedly associated with better prognosis among elderly cardiovascular patients. On the other hand, a metabolic syndrome-type state is characterized by high synthesis and decreased absorption of cholesterol.

METHODS: This was a prospective cohort study of home-dwelling individuals age 75 years and older with cardiovascular diseases (247 women, 129 men) recruited from the community. Main outcome measure was multivariate-adjusted time to 3.4-year mortality and recurrent major cardiovascular events.

RESULTS: Serum total and low-density lipoprotein cholesterol levels did not predict outcome. Instead, the mortality risk (64 deaths) increased with increasing levels of cholestanol-to-cholesterol ratio. Patients in the 2nd, 3rd, and 4th quartiles had a relative hazard ratio (HR) for death of 2.54 (95% confidence interval [CI] 1.05 to 6.12), 2.48 (95% CI 1.03 to 6.00), and 3.53 (95% CI 1.52 to 8.19) compared with the lowest quartile, even though 50% of individuals in the lowest cholestanol quartile had metabolic syndrome or diabetes. In multivariate models, the lowest cholestanol ratio quartile was independently associated with lower mortality (relative HR, 0.37, 95% CI 0.17 to 0.81), and with fewer major cardiovascular events (115 events, relative HR, 0.59, 95% CI 0.35 to 0.98).

CONCLUSIONS: Low cholesterol absorption was associated with fewer recurrent cardiovascular events, and with better survival in elderly patients despite frequent abnormalities of glucose metabolism.

Abbreviations and Acronyms
  APOE = apolipoprotein E
  CI = confidence interval
  DEBATE = Drugs and Evidence-Based Medicine in the Elderly study
  HDL = high-density lipoprotein
  HR = hazard ratio
  HsCRP = high-sensitivity C-reactive protein
  LDL = low-density lipoprotein
  MMSE = Mini-Mental State Examination







HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2006 by the American College of Cardiology Foundation.